tirzepatide maximum weight loss surmount trials SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, SURMOUNT 1 // Three-Year Obesty

Patients on Certain Medications Metformin, proton pump inhibitors, and H2 blockers can reduce B12 absorption over time

Unopened GLP-1 medications stored properly in the refrigerator remain viable until the manufacturer's printed expiration date, which is typically months or years from the production date

Mazdutide A phase II, randomized, double-blind, placebo-controlled trial showed moderate weight loss with mazdutide in Chinese patients with overweight or obesity without T2DM)

Heres how distribution and access impact members: Limited distribution networks can restrict member access based on geography or pharmacy affiliation Prior authorization delays are one of the leading causes of specialty therapy abandonment PBMs with ownership stakes in specialty pharmacies have financial incentives to steer volume regardless of member need Active clinical management of the PA workflow prevents access gaps from becoming care gaps Balancing cost control with patient outcomes